BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.115
-0.005 (-4.17%)
Mar 9, 2026, 3:21 PM AEST

BCAL Diagnostics Revenue

BCAL Diagnostics had revenue of 1.27M AUD in the half year ending December 31, 2025, a decrease of -31.64%. This brings the company's revenue in the last twelve months to 2.54M, down -1.26% year-over-year. In the fiscal year ending June 30, 2025, BCAL Diagnostics had annual revenue of 2.65M, down -13.01%.

Revenue (ttm)
2.54M
Revenue Growth
-1.26%
P/S Ratio
16.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20252.65M-396.37K-13.01%
Jun 30, 20243.05M256.17K9.18%
Jun 30, 20232.79M2.07M288.29%
Jun 30, 2022718.67K443.42K161.09%
Jun 30, 2021275.25K-166.84K-37.74%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
INOVIQ 2.10M
Microba Life Sciences 14.90M
Cryosite 15.75M
Rhythm Biosciences 1.65M
Genetic Signatures 19.94M
Imagion Biosystems 73.03K
Monash IVF Group 269.39M
Genetic Technologies 9.17M
Revenue Rankings